Skip To Main Content

Áreas terapeúticas

Descubra la más reciente actualización sobre la evidencia científica y los datos basados en la vida real que se han recopilado en el campo de la epidemiología. Esta información incluye detalles sobre la carga que estas enfermedades imponen a las personas y a la sociedad en general, así como los métodos de control que se están implementando para hacer frente a estas situaciones.

También se aborda el impacto económico que tienen enfermedades como asma grave, cardiovascular, dermatitis atópica, diabetes o enfermedades raras, etc., en la vida de nuestra población. Estos elementos son fundamentales para comprender la magnitud del problema y para desarrollar estrategias efectivas que ayuden a mejorar la salud pública.

Ordenar por

Patología

Limpiar filtro
  • Filtros
Understanding Cumulative Disease Burden in Uncontrolled AD

Understanding Cumulative Disease Burden in Uncontrolled AD

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.

Understanding Cumulative Disease Burden in Uncontrolled AD

Understanding Cumulative Disease Burden in Uncontrolled AD

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.

Understanding Cumulative Disease Burden in Uncontrolled AD

Understanding Cumulative Disease Burden in Uncontrolled AD

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.

Understanding Cumulative Disease Burden in Uncontrolled AD

Understanding Cumulative Disease Burden in Uncontrolled AD

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

 

MAT-CO-2400825 V1.0 03/2024